Anavex Life Sciences Corp (AVXL)
Equity Ratio
93.60%
Quarterly · Period ending:
AVXL Equity Ratio
Latest reported93.60%period ending
Latest reported93.60%period ending
AVXL Quarterly Equity Ratio (-2663.25% → 93.60%)
Latest values, visible window
High-resolution chart · PNG
AVXL equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 93.5974% | |
| 94.518% | |
| 95.2094% | |
| 91.3827% | |
| 88.7984% | |
| 85.1621% | |
| 89.4166% | |
| 88.7111% | |
| 91.6953% | |
| 93.3969% | |
| 91.5614% | |
| 91.8814% | |
| 92.9946% | |
| 91.1919% | |
| 91.0712% | |
| 93.3116% | |
| 94.0803% | |
| 94.9642% | |
| 93.2894% | |
| 93.3185% | |
| 94.4275% | |
| 90.7101% | |
| 85.2147% | |
| 78.8501% | |
| 78.0299% | |
| 79.9203% | |
| 82.6123% | |
| 80.1034% | |
| 80.2597% | |
| 68.9992% | |
| 77.9328% | |
| 84.0638% | |
| 88.0235% | |
| 86.8057% | |
| 90.1267% | |
| 87.1245% | |
| 94.1599% | |
| 91.0199% | |
| 89.7308% | |
| 66.4109% | |
| 77.9267% | |
| 79.9256% | |
| 81.9404% | |
| 82.7995% | |
| 87.3373% | |
| 73.8847% | |
| 6.7105% | |
| 2.6195% | |
| 79.5442% | |
| 81.6922% | |
| -1,106.9569% | |
| -626.056% | |
| -102,108.1609% | |
| -705,295.2772% | |
| -4,166.0676% | |
| -21,859.4313% | |
| -9,929.0174% | |
| -1,532.3673% | |
| -2,933.2167% | |
| -562.6525% | |
| -76.0966% | |
| -1,895.2324% | |
| -19.1396% | |
| -897.4476% | |
| -462.9491% | |
| -2,452.579% | |
| -6,169.1457% | |
| -944.057% | |
| -338.5668% | |
| -4,021.3925% | |
| -198,922.4387% | |
| -31,751.9047% | |
| -1,503.8349% | |
| -1,092.4697% | |
| -281.924% | |
| -1,850,016% | |
| -382,844.9153% | |
| -1,310.8108% | |
| -615.7219% | |
| -124.1377% | |
| -49.072% | |
| -29,032.3077% | |
| -25,447.6923% | |
| -2,663.2549% |